S.E.A. Medical Systems develops medical devices that instantly identify drugs, concentrations, and diluents in IV fluids while measuring flow rate and cumulative dose to catch life‑threatening IV drug errors. The company is focused on the safety and management of IV medicine and on preventing wrong‑drug and wrong‑dose events in hospitals. Its proprietary technology is being developed for other medical applications beyond IV administration. S.E.A. Medical has been supported by strategic funding and Series A investors including Quantum Technology Partners, New Biology Ventures, and private investors. The company is based in Santa Clara, California. Proceeds from the recent financing will be used to accelerate development of its IV products and expand its technology into additional medical applications.

Total raised

$3M

Funding rounds

1

Latest round

Series B

Latest activity

Jan 2012